Second anti-Chr Ab are specific for SLE but problematic for differentiating SLE (usually at high/medium level) from AID/ID (low level) as reported within the SP-C+ group from the preliminary and cross-sectional analysis [37]. The gene discussed is AICDA; the disease is systemic lupus erythematosus.